Miami Tech & Startup News

Guard Medical of Miami raises $11 million Series B

Guard Medical of Miami raises $11 million Series B

In one of South Florida’s hottest sectors for venture capital, heathcare-technology startup Guard Medical, a Miami-based developer of solutions for surgical wound care to fight off infections, closed an $11 million Series B funding round. Investors participating in the round include Bpifrance and Matignon Investissement et Gestion, the company said.

CEO Machiel van der Leest and his team are developing solutions that enable prophylactic Negative Pressure Wound Therapy (NPWT) for use on a wide range of surgical wound types and sizes with broad applications for infection prevention, scar mitigation and enhanced cosmesis. Its NPWT technology originated with New York-Presbyterian and Weill Cornell Medicine in response to physician’s identification of unmet needs related to Surgical Site Infections.

“The completion of the Series B demonstrates the confidence of the investors to support the next phase of our NPseal. Securing additional funding will enable new clinical studies, increased commercialization and leveraging the NPseal technology into the high exuding and chronic wounds segments,” said van der Leest.

The capital will support commercialization and clinical studies of its NPWT dressing NPseal for the treatment of closed surgical incisions. NPseal is an easy-to-use and cost-effective NPWT surgical dressing with an integrated pump that establishes and maintains negative pressure with just a few pinches. Guard Medical aims to develop NPWT solutions for use on a wide range of surgical wound types and sizes with broad applications for infection prevention, scar mitigation and enhanced cosmesis.

Healthcare technology is one of the top three most active in the Miami-Fort Lauderdale metro area for venture capital.

Follow @ndahlberg on Twitter and email her at ndahlbergbiz@gmail.com

Follow me